• Brain-derived Neurotrophic Factor (BDNF) Genotyping
  • Cryptococcus Antigen, Urine
  • Bladder Tumor Antigen (BTA)
  • Mini Respiratory Pathogen Panel (Influenza A and B, RSV and SARS-CoV-2), Molecular
  • Dengue Virus (1-4) Subtype by PCR
  • TNNC1 (Troponin C) Gene Mutation Analysis
  • 17-Hydroxyprogesterone, Urine
  • Legionella pneumophila Antibody, IgM by IFA
  • Fungal Culture, Blood
  • Lipoprotein Associated Phospholipase A2 Activity
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 27- 29
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 27- 29
Medical Test

Clinical Utility
Access to Cancer Antigen (CA) 27- 29 is restricted.